Quick Heal Tech Q1 FY27 Results (NSE: QUICKHEAL)
Signal: Revenue declined
The read
Revenue declined 21% YoY with consumer business halving, but enterprise order book and deferred revenue surged, and strong other income narrowed the net loss; EBITDA margin remains deeply negative but improved QoQ.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹45 Cr | -21.4% | -7.6% |
| EBIT | ₹-21.4 Cr | -68.5% | |
| Net profit | ₹-5.3 Cr | 4.2% | |
| EPS | ₹-0.9 | 5.4% | |
| EBIT margin | -39.1% |
P&L walk
Revenue decline driven by consumer weakness; EBITDA loss improved QoQ through cost cuts, but remained deep; other income surge cushioned PAT; enterprise pipeline strong with order book and deferred revenue growth.
Key positives
- Order book of ₹56 Cr+ and deferred revenue of ₹52.3 Cr (up 54.7% QoQ) indicate strong enterprise pipeline and future revenue visibility.
- Enterprise revenue held relatively stable (-5.5% YoY) with multi-year order from defence sector and wins in BFSI and IT services.
- Overdues reduced sharply by ~₹70 Cr from H1FY26 to ₹106.6 Cr, showing improved collections in consumer business.
- Other income surged to ₹14.1 Cr (+143% YoY), providing a significant cushion to operating losses and limiting net loss.
Key concerns
- Consumer revenue collapsed 39% YoY to ₹19.2 Cr, reflecting sustained market headwinds and partner credit control impacts.
- Overall revenue contracted 21% YoY, and EBITDA loss remained high at -₹17.6 Cr (39% margin), indicating severe operational inefficiency.
- R&D and S&M costs together account for 109% of revenue (62.4% + 46.4%), far exceeding revenue and driving negative EBITDA.
- Despite other income, the company remains loss-making at both operating and net levels for the fifth consecutive quarter.
Research and educational content only. Not investment advice.